Effect of erytropoetin and Ferinject on transfusio
Phase 2
Recruiting
- Conditions
- Blood transfusion in heart surgery..Iron deficiency anemia
- Registration Number
- IRCT20221021056256N1
- Lead Sponsor
- The Shahid Beheshty University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
These patients are divided into two groups, male and female. In the female group, hemoglobin is less than 12 and in the male group, hemoglobin is less than 13 is considered anemia.
Exclusion Criteria
History of allergy to iron.
liver disease
evidence of iron overload
pediatrics
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of blood transfusions. Timepoint: 5_7 day before surgery. Method of measurement: pack cell.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie erythropoietin and ferrous iron's effect on reducing blood transfusion rates in cardiac surgery patients with iron deficiency anemia?
How does the combination of preoperative erythropoietin and Ferinject compare to standard blood transfusion protocols in adult cardiac surgery outcomes?
Which biomarkers are associated with response to erythropoietin and intravenous iron therapy in patients undergoing cardiac surgery with iron deficiency anemia?
What are the potential adverse events and management strategies for erythropoietin and Ferinject in preoperative cardiac surgery patients?
Are there alternative iron supplementation approaches or competitor drugs to Ferinject in combination with erythropoietin for cardiac surgery anemia management?